Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

ANNALS OF ONCOLOGY

ELSEVIER

1. Forschungskredit University of Zurich [54171101]
2. Swiss Cancer League [KFS-3115-02-2013]
3. Cancer Research Institute
4. Ludwig Institute for Cancer Research
5. 'Hoch-spezialisierte Medizin Schwerpunkt Onkologie und Schwerpunkt Immunologie (HSM-2-Immunologie)' of the Canton Zurich, Switzerland